Outcome of Board Meeting

Q1FY27 results (unaudited): Standalone: Revenue 13.5bn +27% y-y (10.6bn) PAT 15.1bn +1487% y-y (0.78bn) Consolidated: Revenue 45.6bn +6% y-y (43.1bn) EBITDA 20.3bn +313% y-y (4.9bn) EBITDA margin 44.5% (11.5%) +3300 bps y-y PAT 11.1bn vs loss of 0.32bn y-y FY26 results (audited): Standalone: Revenue 32.9bn +13% y-y (29.1bn) EBITDA 2.3bn (derived, see notes) PAT 6.1bn +680% y-y (0.78bn) Consolidated: Revenue 89.7bn +42% y-y (63.9bn) EBITDA 2.3bn (derived, see notes) PAT (3.2bn) vs (0.99bn) loss y-y Dividend: None stated Commentary: Exceptional impairment loss of 1.085bn recognized on investment in subsidiary HHT in Q1FY27.